A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.
Due to a lack of noticeable symptoms in its early stages and the pancreas’ obscure location behind other organs in the ...
Pancreatic enzyme replacement therapy (Pert) provides the enzymes people affected by pancreatic cancer need to absorb ...
An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...
Most pancreatic cancer isn’t caught until it’s late stage — a new blood test could change that
The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results